Large vaccine trials that are extensive both in size and scope tax the resources of sponsors and contract research organizations (CROs), particularly when the trials seek to compress a process that ordinarily takes years. Rapid but safe implementation of these vaccine studies’ new protocols is pushing trial design to the limit.

Syneos Health announced an agreement to acquire Synteract, a full-service contract research organization (CRO) focused on the biopharmaceutical industry.

The UK government’s Covid-19 Vaccine Taskforce and the contract research company Open Orphan announced a $13 million (£10 million) plan to test investigational vaccines in volunteers who are then intentionally exposed to SARS-CoV-2, the virus that causes Covid-19.

Andrea Bastek – Director of Innovation at Florence, the largest eISF + Remote Site Access platform in clinical research – discusses three ways in which sponsors and CROs can increase compliance with a purpose-built, site-centric, remote access platform.

Precision for Medicine – the first comprehensive, fully integrated biomarker-driven clinical research services organization – announced that veteran healthcare leader Mairead Kehoe was named the CRO’s new Executive Vice President, responsible for overseeing global clinical solutions delivery.

Syneos Health Inc. announced the acquisition of Kinapse – a market leading advisory and operational solutions provider to the global life sciences industry – from Hg, a specialist investor based in the U.K.

Charles River Laboratories, a contract research organization (CRO) with headquarters in Wilmington, Mass., is buying MPI Research for about $800 million.

Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the appointment of Lisa van Capelle as Chief Human Resources Officer (CHRO).

Reaction Biology Corporation, a leading contract research organization providing early-stage drug discovery services, announced that it has launched a new division to provide ion-channel discovery services.